Mind‐Body Therapies in the Management of Otolaryngologic Disease: A State‐of‐the‐Art Review of Randomized Controlled Trials

Abstract

AbstractObjectiveTo review and assess the peer‐reviewed literature on the utility of mind‐body therapy (MBT) as an adjunct treatment in the management of otolaryngologic disease.Data SourcesPubMed, Embase, and Cochrane.Review MethodsRandomized control trials (RCTs) of MBTs in the management of otolaryngologic disease from 2002 to 2022 were identified and included according to predefined criteria. Interventions requiring expensive equipment were excluded because the goal of MBT is to be cost‐conscious. All studies were subjected to a two‐stage blinded screening, extraction, and appraisal process. The outcomes of the intervention and control groups were compared.ConclusionRCTs of MBTs, including breathing exercises (4), aromatherapy (2), biofeedback (2), meditation, (2), and yoga (2), have been studied in several otolaryngologic conditions, including septoplasty/rhinoplasty (3), head and neck cancer (2), facial palsy (2), and tinnitus (2). Most studies were of moderate risk of bias on appraisal, and each MBT studied was found to significantly reduce subjective and objective distress associated with the otolaryngologic condition in question.Implications for PracticeDespite a paucity of strong evidence supporting the universal use of MBTs, our review suggests that MBTs are cost‐effective and easily deployable complementary tools in the management of otolaryngologic disease. Future large, methodologically rigorous RCTs are needed to address the limitations of the included studies, such as improper blinding and inappropriate statistical analysis. As MBTs are studied further, a case for their current use can be made because of their low cost and minimal risk to patients.